Anne Wojcicki's nonprofit TTAM acquires 23andMe for $305 million, ending the gene-testing pioneer's bankruptcy saga. The deal still faces state regulators' objections over genetic data control.

The 40 Under 40, Evan Hill of Cravath, Swaine & Moore is honored for his work in bankruptcy and restructuring.

The sale was previously approved by a judge. The company was purchased by the nonprofit TTAM Research Institute, which is led by 23andMe cofounder Anne Wojcicki.

Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court’s green light.

Office of the Utah Attorney General and the Utah Department of Commerce’s Division of Consumer Protection are issuing a consumer alert to Utahns, advising residents of the Beehive State ...

A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe's co-founder and former chief executive, Anne Wojcicki.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s nonprofit acquires 23andMe.

Illumina sees new pharma interest, even as its business suffers several hits from NIH funding and a DOJ settlement.

According to Wojcicki, panda parenting, an answer to the flawed helicopter parenting style, is an approach that promotes independence, personal responsibility and healthy self-esteem; “Panda ...

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet issue for Commissioner Marty Makary that’s separately garnered attention in ...